Abstract

PURPOSE Head lice (pediculosis capitis) affects approximately 6-12 million children in the United States each year, with resistance to currently available head lice treatments increasing. The majority of these treatments require two applications, applied 7-10 days apart. Abametapir lotion 0.74% is a new single-application product for the treatment of head lice infestation. A Phase 2b study conducted in children aged ≥2 years demonstrated that a single application of abametapir lotion (0.74% w/w) resulted in 86% of subjects being lice-free at 14 days post-treatment [1]. These …

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.